SUBSCRIBE
SUBSCRIBE

Novartis

NEWS
Novartis Unloads Former New York Space for $18 Million, Resold for $30 Million
Drug Development
A First: Novartis AG Drug May Prevent Heart Attacks and Cut Lung Cancer Risk Too
August 28, 2017
 · 
2 min read
Tiny KalVista Explodes on $760 Million Deal With Drug Giant Merck & Co.
Business
Novartis AG Pays $31 Million+ for XOMA ‘s Failed Phase III Drug
August 25, 2017
 · 
3 min read
Novartis Unloads Former New York Space for $18 Million, Resold for $30 Million
Business
Novartis AG Lures Superstar Scientist Away From UCSF
August 17, 2017
 · 
3 min read
Novartis to Hold On to Its 33% Stake in Roche—For Now
Deals
Novartis AG Boss Updates Q2 Financials and Reaffirms M&A Strategy
July 19, 2017
 · 
3 min read
Business
Novartis AG’s Long-Suffering Alcon Sees Sales Growth in Q2, Opening Door to Spin-Off IPO
July 18, 2017
 · 
1 min read
Novartis to Hold On to Its 33% Stake in Roche—For Now
Novartis AG Stocking Up on “Big-3" Arthritis Blockbusters to Get an Edge on Rivals
July 14, 2017
 · 
2 min read
What You Missed: Nippon Fine Chemical Formed Human Barricade to Stop FDA Employee
FDA
FDA Panel Unanimously Endorses Novartis AG’s CAR-T Leukemia Drug
July 13, 2017
 · 
3 min read
Policy
Novartis AG Avoided Deaths In CAR-T Trials But Long-Term Safety Is Key, Says The FDA
July 11, 2017
 · 
1 min read
Massachusetts' Biostage Slashes 71% of Staff, Evaluating Strategic Alternatives
Policy
Waiting Lists are Already Forming for Novartis AG and Kite Pharma’s Not-Yet Approved CAR-T Drugs
July 7, 2017
 · 
3 min read
Load More
AWARDS
  • 2022 Best Places to Work
  • 2024 Best Places to Work
JOBS
IN THE PRESS
Press Releases
New PSMAddition data show 58% lower risk of PSA progression with Pluvicto® in metastatic hormone-sensitive prostate cancer
May 17, 2026
 · 
8 min read
Press Releases
Novartis Canada launches third edition of its Health Equity Initiative, prioritizing Women’s Health
May 14, 2026
 · 
4 min read
Press Releases
Novartis breaks ground on Denton, Texas radioligand therapy site; construction now underway across all new US facilities
May 7, 2026
 · 
8 min read
Press Releases
Novartis Canada Recognizes MS Awareness Month with the Third Annual My Krew Campaign
May 4, 2026
 · 
6 min read
Press Releases
Novartis receives Health Canada approval for Fabhalta® oral treatment for adults with C3G
May 4, 2026
 · 
4 min read
Press Releases
Novartis finalizes US manufacturing and R&D expansion plan with seventh new facility
April 30, 2026
 · 
6 min read
Press Releases
Dubai’s Medcare Hospital Becomes the World’s First to Treat an Adult Spinal Muscular Atrophy (SMA) Patient Outside the US
April 28, 2026
 · 
2 min read
Press Releases
Novartis delivered strong growth in priority brands and launches in Q1; FY 2026 guidance reaffirmed
April 28, 2026
 · 
19 min read
Press Releases
Novartis Rhapsido® receives European Commission approval as first oral targeted treatment for chronic spontaneous urticaria
April 27, 2026
 · 
10 min read
Press Releases
Novartis receives positive CHMP opinion for Itvisma® for spinal muscular atrophy (SMA)
April 24, 2026
 · 
8 min read
Load More